KATHLEEN DALTON: Open Payments
NPI 1295497808 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 41 payments from 11 companies in 2025. Trend: 2023 $785 · 2024 $853 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $263 |
| Alkermes, Inc. | 7 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Corium, LLC | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: VRAYLAR, LYBALVI, UZEDY, COBENFY, Azstarys, Auvelity, INGREZZA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
